BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20403914)

  • 1. Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk.
    Tindall EA; Severi G; Hoang HN; Ma CS; Fernandez P; Southey MC; English DR; Hopper JL; Heyns CF; Tangye SG; Giles GG; Hayes VM;
    Carcinogenesis; 2010 Oct; 31(10):1748-54. PubMed ID: 20403914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.
    Nam RK; Zhang WW; Klotz LH; Trachtenberg J; Jewett MA; Sweet J; Toi A; Teahan S; Venkateswaran V; Sugar L; Loblaw A; Siminovitch K; Narod SA
    Clin Cancer Res; 2006 Nov; 12(21):6452-8. PubMed ID: 17085659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 promoter variants, prostate cancer risk, and survival.
    Tindall EA; Severi G; Hoang HN; Southey MC; English DR; Hopper JL; Giles GG; Hayes VM;
    Prostate; 2012 Dec; 72(16):1701-7. PubMed ID: 22782910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.
    Nam RK; Zhang WW; Loblaw DA; Klotz LH; Trachtenberg J; Jewett MA; Stanimirovic A; Davies TO; Toi A; Venkateswaran V; Sugar L; Siminovitch KA; Narod SA
    Prostate Cancer Prostatic Dis; 2008; 11(3):241-6. PubMed ID: 17876339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
    Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
    Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
    Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
    Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association and gene-gene interactions of eight common single-nucleotide polymorphisms with pediatric asthma in middle china.
    Wu X; Li Y; Chen Q; Chen F; Cai P; Wang L; Hu L
    J Asthma; 2010 Apr; 47(3):238-44. PubMed ID: 20394509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.
    Lindmark F; Zheng SL; Wiklund F; Bensen J; Bälter KA; Chang B; Hedelin M; Clark J; Stattin P; Meyers DA; Adami HO; Isaacs W; Grönberg H; Xu J
    J Natl Cancer Inst; 2004 Aug; 96(16):1248-54. PubMed ID: 15316060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of non-HLA genetic variants in end-stage renal disease.
    Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
    Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.
    Farjadfar A; Mojtahedi Z; Ghayumi MA; Erfani N; Haghshenas MR; Ghaderi A
    Acta Oncol; 2009; 48(7):971-6. PubMed ID: 19642044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
    Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
    Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of chromosomal locus 8q24 and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
    Meyer A; Schürmann P; Ghahremani M; Kocak E; Brinkhaus MJ; Bremer M; Karstens JH; Hagemann J; Machtens S; Dörk T
    Urol Oncol; 2009; 27(4):373-6. PubMed ID: 18625567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness.
    Cicek MS; Nock NL; Li L; Conti DV; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1331-6. PubMed ID: 15298954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2 gene promoter haplotypes and prostate cancer risk.
    Panguluri RC; Long LO; Chen W; Wang S; Coulibaly A; Ukoli F; Jackson A; Weinrich S; Ahaghotu C; Isaacs W; Kittles RA
    Carcinogenesis; 2004 Jun; 25(6):961-6. PubMed ID: 14754878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two common chromosome 8q24 variants are associated with increased risk for prostate cancer.
    Wang L; McDonnell SK; Slusser JP; Hebbring SJ; Cunningham JM; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
    Cancer Res; 2007 Apr; 67(7):2944-50. PubMed ID: 17409399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cytokine gene polymorphisms on the development of prostate cancer.
    McCarron SL; Edwards S; Evans PR; Gibbs R; Dearnaley DP; Dowe A; Southgate C; Easton DF; Eeles RA; Howell WM
    Cancer Res; 2002 Jun; 62(12):3369-72. PubMed ID: 12067976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study.
    Eder T; Mayer R; Langsenlehner U; Renner W; Krippl P; Wascher TC; Pummer K; Kapp KS
    Eur J Cancer; 2007 Feb; 43(3):472-5. PubMed ID: 17182240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in tumor necrosis factor-A gene and prostate cancer risk in North Indian cohort.
    Kesarwani P; Mandhani A; Mittal RD
    J Urol; 2009 Dec; 182(6):2938-43. PubMed ID: 19846139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.